26 - 27 November, 2019 | Millennium Gloucester Hotel London Kensington, London, United Kingdom

Day Two

8:00 - 8:45 Registration and Welcome Coffee

Dr Sven Bostyn Lic.Jur., LLM, PhD, Associate Professor of Biomedical Innovation Law at Law Center for Advanced studies in Biomedical Innovation Law

Dr Sven Bostyn Lic.Jur., LLM, PhD

Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law

9:00 - 9:30 Patent Infringement and Second Medical Use Claims: A Problem That Is Not a Problem?

Courts across Europe have struggled with the question of patent infringement of second medical use claims. A solution is in fact not that difficult and is at hand, but it will require involvement of the legislator. Dr. Sven Bostyn will address this issue, exploring:
·         Second medical use claims and patent infringement
·         Legal uncertainty across Europe
·         How this effects both innovators and generic companies
·         A solution that will remove the majority of the uncertainty
Dr Sven Bostyn Lic.Jur., LLM, PhD, Associate Professor of Biomedical Innovation Law at Law Center for Advanced studies in Biomedical Innovation Law

Dr Sven Bostyn Lic.Jur., LLM, PhD

Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law

9:30 - 10:00 When All Comes Together: Change the way of Searching Prior-Art in Life Science

Orbit BioSequence is the only software platform that allows IPR professionals to do sequence searching in a fully featured patent platform. It is entirely made for IP searchers and allows you to see sequence alignments in a patent and family context.
 
Denis Bayada of Questel and the creator of Orbit BioSequence will discuss how his solution can combine and analyse:
·         Sequence searches
·         Small molecule searches
·         Text, concepts and legal status searches
Denis Bayada, Product Manager Orbit at Questel

Denis Bayada

Product Manager Orbit
Questel

Fabienne Persijn, Key Account Executive at Questel

Fabienne Persijn

Key Account Executive
Questel

10:00 - 10:30 Overcoming the Inventive Step

One of the conditions for the grant of a patent is that the invention involves an “inventive step.”   An invention shall be taken to involve an inventive step if it is not obvious to a person skilled in the art, having regard to any matter which forms part of the state of the art. Jane Lambert will be discussing:
·         What is and is not considered ‘obvious’?
·         How recent Supreme Court cases such as the Actavis Group PTC EHF (et al.) v ICOS Corporation [2019] UKSC 15 affects the definition of ‘obvious’
·         How the Arrow Declaration will impact the Inventive step
Jane Lambert QC, Barrister at 4-5 Gray's Inn Square

Jane Lambert QC

Barrister
4-5 Gray's Inn Square

10:30 - 11:00 Morning Break and Networking

This panel will address the challenges of developing a patent portfolio in an era of lengthier product development timelines, more stringent patent office processes and increasing competition. Our panel will discuss:
·         Real-world examples of creative patent commercialisation
·         Outside of the box ideas and theories for commercialisation strategies
·         What is and is not feasible in the commercial realm
Harriet Strimpel, Chief IP Counsel at New England Biolabs

Harriet Strimpel

Chief IP Counsel
New England Biolabs

Dr Guido Pontremoli, Corporate IP Patent Director at Chiesi

Dr Guido Pontremoli

Corporate IP Patent Director
Chiesi

Susan Dunn, CEO at Harbour Litigation Fund

Susan Dunn

CEO
Harbour Litigation Fund

12:00 - 12:30 Lessons Learned from a Funder of IP Litigation

Harbour Litigation’s funds (which now amount to £750 million) have financed over 150 claims globally. They are the experts in funding IP cases.  In this presentation, Susan Dunn, Founder of Harbour will discuss:
·         How to get a case funded and typical terms for funded parties
·         How to value your claim
·         Specific issues when litigating in the UK, Germany and the US
Susan Dunn, CEO at Harbour Litigation Fund

Susan Dunn

CEO
Harbour Litigation Fund

12:30 - 13:30 Networking Lunch

13:30 - 14:00 Patent Enforcement Strength in 52 Countries Worldwide:Implications for Your Patent Filing Litigation Strategies

The strength and effectiveness of patent enforcement in a country is one of the aspects considered when developing your patent filing and litigation strategies. Nikolaos will be discuss:
·         The latest assessment of the levels of patent enforcement strength in 52 countries worldwide
·         Identifying countries where you should anticipate that the enforcement of your patents is likely to be problematic.
·         Understanding which countries could be earmarked or dropped out of patent filing and renewing decisions, from the perspective of patent enforcement strength.
·         If you should be enforcing your patents in China?
Nikolaos Papageorgiadis, Senior Lecturer at University of Liverpool

Nikolaos Papageorgiadis

Senior Lecturer
University of Liverpool

14:00 - 15:00 Interactive Discussion Groups


·         ALTERNATIVE DISPUTE RESOLUTIONS
·         FINDING IP AGREEMENT IN COLLABORATION BETWEEN ACADEMICS AND BUSINESS DURING R&D
·         GETTING SCIENTISTS ON YOUR SIDE
·         WORLDWIDE LAWMAKERS AREN’T KEEPING UP WITH THE RATE OF LIFE SCIENCE R&D – WHAT CAN WE DO?
·         COLLABORATION OF INHOUSE COUNSEL AND EXTERNAL FIRMS FOR EFFECTIVE IP STRATEGY
To conclude our event, our chairperson will be hosting a wind-down session to reflect on the insights gleaned throughout the course of the previous two days.
 
The session will focus on the tangible takeaways from the conference. This session will be aided by audience participation, allowing the attendees to share what they have found most useful and insightful that they will go on to apply to their IP strategy.
Dr Sven Bostyn Lic.Jur., LLM, PhD, Associate Professor of Biomedical Innovation Law at Law Center for Advanced studies in Biomedical Innovation Law

Dr Sven Bostyn Lic.Jur., LLM, PhD

Associate Professor of Biomedical Innovation Law
Law Center for Advanced studies in Biomedical Innovation Law